Skip to content
Menu

Investors

Lien vers Boursorama

Quote of the day

22/06/2025 20h42
0,2085 €
Follow-up of the actions summary
Follow-up of the OCA-BSA program
Follow-up of the BSA K program
Follow-up of the BSA E program

The latest information

ARCHOS 2025

Annual Financial Report 2023

French

Capital transactions

Fin du recours au programme de financement en OCA en vigueur avec Yorkville Advisors

Augmentation de capital avec maintien du droit préférentiel de souscription des actionnaires faisant suite à la constitution, par le management, d’un noyau dur d’actionnaires à hauteur de 30% du capital

Utilisation du produit d’émission des augmentations de capital pour rembourser Yorkville Advisors et la fiducie-gestion

French

Financial results for FY 2023: sales up 38% and improved operating income

French

DOMISANTE, a subsidiary of Medical Devices Venture, an ARCHOS Group start-up studio, is integrating access to tele-expertise and patient diaries for healthcare professionals into its digital health gateway.

French

Reduction of share capital by reducing the par value of shares – Transfer of registered office

French

151% pro forma sales growth in 2023, after integration of 12 months of Elexo, 37% growth including November and December 2023, post-acquisition

French

Archos announces the establishment of a management trust following the acquisition of blocks of MDV shares, in connection with the proposed delisting of MDV shares from the Euronext Access+ Paris market.

French

Shares and voting rights at 11/30/2023

French

+